News

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...
Despite Africa bearing the brunt of infections and deaths, wealthy nations continue stockpiling Jynneos vaccine ...